These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3886577

  • 1. Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil.
    Jacobs MJ, Lemmens HA.
    Int J Microcirc Clin Exp; 1985; 4(1):63-8. PubMed ID: 3886577
    [Abstract] [Full Text] [Related]

  • 2. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R, Shariat K, von Wilmowsky H, Böhm M.
    Circulation; 2005 Nov 08; 112(19):2980-5. PubMed ID: 16275885
    [Abstract] [Full Text] [Related]

  • 3. Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up.
    Le Quentrec P, Lefebvre ML.
    Angiology; 1991 Apr 08; 42(4):289-95. PubMed ID: 1673051
    [Abstract] [Full Text] [Related]

  • 4. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study.
    Jacobs MJ, Jörning PJ, Van Rhede van der Kloot EJ, Kitslaar PJ, Lemmens HA, Slaaf DW, Reneman RS.
    Int J Microcirc Clin Exp; 1991 Feb 08; 10(1):1-11. PubMed ID: 2019479
    [Abstract] [Full Text] [Related]

  • 5. [Capillaroscopy and Raynaud's phenomenon].
    Carpentier P, Franco A.
    J Mal Vasc; 1984 Feb 08; 9(1):23-8. PubMed ID: 6707531
    [Abstract] [Full Text] [Related]

  • 6. Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud's syndrome: a randomised trial.
    Tucker AT, Pearson RM, Cooke ED, Benjamin N.
    Lancet; 1999 Nov 13; 354(9191):1670-5. PubMed ID: 10568568
    [Abstract] [Full Text] [Related]

  • 7. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.
    Lee P, Sarkozi J, Bookman AA, Keystone EC, Armstrong SK.
    J Rheumatol; 1986 Jun 13; 13(3):564-9. PubMed ID: 3735278
    [Abstract] [Full Text] [Related]

  • 8. Ketanserin and capillary flow in Raynaud's phenomenon.
    Tooke JE, Williams SA, Rawlinson DW, Black C.
    Int J Microcirc Clin Exp; 1990 Aug 13; 9(3):249-55. PubMed ID: 2394546
    [Abstract] [Full Text] [Related]

  • 9. [The use of capillary videomicroscopy in the therapeutic assessment of acral vasospastic phenomena: microcirculatory effect of ketanserin and nifedipine].
    Gasser P.
    Schweiz Rundsch Med Prax; 1994 Apr 26; 83(17):511-4. PubMed ID: 8191194
    [Abstract] [Full Text] [Related]

  • 10. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z.
    Auton Neurosci; 2004 Nov 30; 116(1-2):62-8. PubMed ID: 15556839
    [Abstract] [Full Text] [Related]

  • 11. Local cold exposure test as therapy control in patients with Raynaud's phenomenon: comparison between laser Doppler fluxmetry and simultaneous red blood cell velocity measurements in nailfold capillaries.
    Hahn M, Klyscz T, Jünger M, Rassner G.
    Br J Dermatol; 1995 Nov 30; 133(5):704-9. PubMed ID: 8555020
    [Abstract] [Full Text] [Related]

  • 12. Treatment of the Raynaud's phenomenon with piracetam.
    Moriau M, Lavenne-Pardonge E, Crasborn L, von Frenckell R, Col-Debeys C.
    Arzneimittelforschung; 1993 May 30; 43(5):526-35. PubMed ID: 8328997
    [Abstract] [Full Text] [Related]

  • 13. Nailfold capillaroscopy and laser Doppler fluxmetry for evaluation of Raynaud's phenomenon: how valid is the local cooling test?
    Creutzig A, Hiller S, Appiah R, Thum J, Caspary L.
    Vasa; 1997 Aug 30; 26(3):205-9. PubMed ID: 9286153
    [Abstract] [Full Text] [Related]

  • 14. Double-blind capillaroscopic study of the activity of buflomedil in Raynaud's syndrome: a report on 80 cases.
    Courbier R, Bergeron P, Fouque R.
    Angiology; 1981 Oct 30; 32(10):676-8. PubMed ID: 7325403
    [Abstract] [Full Text] [Related]

  • 15. Laser Doppler flowmeter and standardized thermal test in normals and Raynaud's phenomenon.
    Boccalon HJ, Marguery MC, Ginestet MC, Puel PF.
    Int Angiol; 1987 Oct 30; 6(2):107-18. PubMed ID: 3323348
    [Abstract] [Full Text] [Related]

  • 16. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T, Komiyama T, Onozuka A, Miyata T, Shigematsu H.
    Eur J Vasc Endovasc Surg; 2004 Apr 30; 27(4):414-6. PubMed ID: 15015193
    [Abstract] [Full Text] [Related]

  • 17. Microcirculatory and clinical effects of serial percutaneous application of carbon dioxide in primary and secondary Raynaud's phenomenon.
    Schmidt J, Monnet P, Normand B, Fabry R.
    Vasa; 2005 May 30; 34(2):93-100. PubMed ID: 15968890
    [Abstract] [Full Text] [Related]

  • 18. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 May 30; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 19. Influence of local finger cooling on laser Doppler flux and nailfold capillary blood flow velocity in normal subjects and in patients with Raynaud's phenomenon.
    Lütolf O, Chen D, Zehnder T, Mahler F.
    Microvasc Res; 1993 Nov 30; 46(3):374-82. PubMed ID: 8121320
    [Abstract] [Full Text] [Related]

  • 20. Total and capillary fingertip blood flow in Raynaud's phenomenon.
    Coffman JD, Cohen AS.
    N Engl J Med; 1971 Jul 29; 285(5):259-63. PubMed ID: 5090397
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.